A survey of the quality of generic clarithromycin products from 13 countries

Clinical Drug Investigation

Volumn 19, Issue 4, 2000, Pages 293-305

  Nightingale, C H ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6,11 DIMETHYLERYTHROMYCIN A; BICROLID; CLACINE; CLAMBIOTIC; CLAMYCIN; CLARIBAC; CLARICIDE; CLARIMAX; CLARIMICIN; CLARION; CLARITHRO 250; CLARITHROMYCIN; CLARITROBAC; CLARITROL; CLARITROMICINA; CLARITROMICINA MK; COMTRO; CRIXAN; DICUPAL; ERYTHROMYCIN DERIVATIVE; GENERIC DRUG; INFEX; KLARID; KLAROLID; KLAROMIN; KLAX; LIMAIXIAN; MACROL; MACROLIEN; MUS; PRE CLAR; SYNCLAR; UNCLASSIFIED DRUG;

ARTICLE; ASIA; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG PURITY; DRUG QUALITY; DRUG RELEASE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; TABLET;

EID: 0034088132     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200019040-00007     Document Type: Article

References (13)

1. 1. Langtry HD, Brogden RN. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients. Drugs 1997; 53: 973-1004
2. 2. Peters DH, Clissold SJ. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs 1992; 44: 117-64
3. 3. Bogossian M. Use of clarithromycin for respiratory infections in general practice. Rev Bras Med 1995; 52: 500-9
4. 4. Farhat CK. Use of clarithromycin in respiratory infections in pediatrics. Mod Pediatr 1995; 31: 1-8
5. 5. Endo LH. The use of clarithromycin in respiratory infections in general practice. Otorinolaringologia 1995; 2: 1-8
6. 6. Morgan DK, Brown DM, Rotsch TD, et al. A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms. J Pharm Biomed Anal 1991; 9: 261-9
7. 7. Morgan DK, Cugier P, Marello B, et al. Impurity profiling of clarithromycin using high-performance liquid chromatography with ultraviolet detection. J Chromatogr 1990; 502: 351-8
8. 8. Davidson AG, McCallum A. Drug Develop Ind Pharm 1996; 22: 1173
9. 9. Ishii K, Katayama Y, Itai S, et al. In vitro dissolution tests corresponding to the in vivo dissolution of clarithromycin tablets in the stomach and intestine. Chem Pharm Bull 1995; 43: 1943-8
10. 10. Qureshi SA, McGilveray IJ. Assessment of pharmaceutical quality of furosemide tablets from multinational markets. Drug Dev Ind Pharm 1998; 24: 995-1005
11. 11. Brittain HG, editor. Analytical profiles of drug substances. Vol. 24. New York: Academic Press, 1996
12. 12. CPMP/ICH/282/95 Step 4, Consensus Guideline, 6 November 1996
13. 13. USP 24, The United States Pharmacopeia, The United States Pharmacopeial Convention Inc., Rockville, MD, USA 1999